Endogenous IL-1 receptor antagonist restricts healthy and malignant myeloproliferation.
Villatoro A, Cuminetti V, Bernal A, Torroja C, Cossío I, Benguría A, Ferré M, Konieczny J, Vázquez E, Rubio A, Utnes P, Tello A, You X, Fenton CG, Paulssen RH, Zhang J, Sánchez-Cabo F, Dopazo A, Vik A, Anderssen E, Hidalgo A, Arranz L.
Villatoro A, et al. Among authors: dopazo a.
Nat Commun. 2023 Jan 3;14(1):12. doi: 10.1038/s41467-022-35700-9.
Nat Commun. 2023.
PMID: 36596811
Free PMC article.